The BMI Story Is Really a Cholesterol and Blood Pressure Story

Originally surfaced July 8, 2026, drawing on a July 1 Lancet study and STAT coverage of changing cholesterol and blood-pressure patterns by BMI.

A new Lancet analysis makes an easy headline tempting: adults with obesity over age 40 now look much closer to adults with normal BMI on blood pressure and unhealthy cholesterol than they did three decades ago.

That is true as far as the measured risk factors go. It is not the same as saying obesity became harmless, or that cardiometabolic risk can be read from body size alone.

The study, from the NCD Risk Factor Collaboration, analyzed national population-based datasets from seven industrialized countries. PubMed lists the Lancet article as published July 1, 2026, with the title "Metabolic traits in obesity and normal BMI in industrialised countries: a multi-country analysis of national population-based studies." STAT reported that the analysis included 110 datasets and about 1 million participants from 1990 through 2024.

What changed after age 40

The main finding is a convergence story. Since 1990, blood pressure and unhealthy cholesterol fell more sharply among adults with overweight or obesity who were 40 to 79 years old than among adults of the same age with normal BMI. By 2024, STAT reported, adults in their 60s and 70s with overweight or obesity had blood pressure and unhealthy cholesterol levels similar to, and in some comparisons lower than, peers with normal BMI.

That pattern was not seen in the same way for adults under 40. STAT's coverage notes that younger adults were much less likely to be receiving cholesterol or blood-pressure medication, regardless of BMI group.

The likely explanation is not mysterious. Statins, blood-pressure drugs, screening, and preventive cardiology became much more common over the study period. Those tools appear to have narrowed some of the measured gaps between BMI groups in middle-aged and older adults.

What not to overread

This was an observational analysis. It cannot prove that medication use caused every trend, and it cannot show that equal cholesterol and blood-pressure readings mean equal long-term risk.

That caveat matters. BMI is only one crude body-size measure. Blood pressure and lipid numbers are measured risk factors. Diabetes risk, inflammation, kidney disease, liver fat, genetics, smoking, diet, activity, and medication access can all complicate the picture. A person can have a normal BMI and high LDL. A person can have obesity and treated cholesterol. Neither case is captured well by body size alone.

The Lancet finding also does not mean earlier exposure disappears. STAT quotes outside and study-linked experts warning that years of elevated blood pressure or cholesterol can leave lasting vascular risk even if later numbers improve.

Where lab testing fits

For LabTestSuperstore readers, the practical lab angle is narrow: cardiometabolic risk is measured through markers, not guessed from appearance.

A lipid panel measures total cholesterol, LDL, HDL, and triglycerides. An ApoB test can add particle-count context for atherogenic lipoproteins. Lp(a), hs-CRP, glucose, A1c, and a broader heart health panel can each answer different questions about cardiovascular or metabolic risk.

Those results do not diagnose cardiovascular disease by themselves, and they do not decide whether someone needs medication. They give concrete numbers for a clinician conversation that can otherwise get reduced to weight, age, family history, or a vague sense of being "healthy."

The useful takeaway

The study is good news for preventive cardiology, but only in a specific sense. It suggests that treatment and screening have narrowed some cholesterol and blood-pressure gaps among older adults with higher BMI. It does not make BMI irrelevant, does not make obesity benign, and does not remove the need to measure the risk factors that treatment is supposed to improve.

For lab testing, that is the clean point: body size is not a cholesterol result, not a blood-pressure reading, not an ApoB value, and not an A1c. The numbers still matter.

This article is editorial commentary and is not medical advice. It has not been reviewed by a physician and should not be used to make decisions about diagnosis, cholesterol treatment, blood-pressure treatment, weight-loss medication, cardiovascular care, diabetes care, or testing frequency.